HK, US stocks top stories
VIVA BIOTECH's incubated enterprise investment received a merger and acquisition with a maximum cost of 47 million USDCIFI HOLD GP signs a three-year option agreement with fund LMR, receiving an advance payment of 276 million yuanChange of Chairman and CEO of PAX GLOBALHEARTCARE-B issues domestic shares to vice president, raising a net amount of 43.25 million yuanKINGLAND GROUP offers a 19.95% discount on its placement, netting CNY 70.76 millionPAGODA GP's controlling shareholder plans to increase holdings by no more than 10 million sharesFUSEN PHARM's application for the consistency evaluation of Nicardipine Hydrochloride Injection has been approved for marketingZHENGYE INT'L sells Zhongshan industrial property, realizing RMB 8.81 millionKINGLAND GROUP suggests changing its name to "Intelligent Computing Energy Construction Holdings"YUEXIU PROPERTY's contract sales in November fell by 49%, achieving 81% of the target for the first eleven monthsSHUN WO GROUP raises HKD 18.67 million by offering three shares for every one share at HKD 0.14 per shareHENLIUS's new indication drug registration application has been accepted